Home » Newsletters » BioWorld Science

BioWorld Science

May 26, 2016

View Archived Issues

New drug for GI radiation injury

ABLS II completes drug candidate feasibility program

CD31 expression on CD4 T cells correlated with respiratory disease in premature infants

P2Y6 receptor identified as a therapeutic target for asthma

Monoclonal antibody targets gastric inhibitory polypeptide to treat obesity

Acad10 gene knockout mice are a potential model of diabetes

Lundbeck patents BACE1 inhibitors

Bristol-Myers Squibb divulges IDO inhibitors to treat cancer

Lysosomal Therapeutics announces glucosylceramidase activators

Amorsa Therapeutics presents NMDA receptor antagonists

Eli Lilly introduces drug conjugates for bone disorders

Seed funding for Global Antibiotic Research and Development partnership

FDA will not meet PDUFA date for Sarepta's eteplirsen NDA

Eisai launches Fycompa tablets in Japan

Tetragenetics begins partnership with Theranyx

FDA grants fast track status to Novavax's RSV F vaccine

Alkermes begins phase I trial of ALKS-4230

Successful phase II results for solithromycin in community-acquired bacterial pneumonia

Kamada's alpha1-antitrypsin is available in Europe via myTomorrows early access platform

FDA advisory committee recommends approval of insulin glargine/lixisenatide

Juno Therapeutics signs intent to collaborate with Seattle Children's

SEATTLE study of emixustat in geographic atrophy fails to meet primary endpoint

BioXcel and Alnylam enter strategic collaboration to discover novel RNAi therapeutics

Michael J. Fox Foundation for Parkinson's Research announces new funding and partnership

FDA grants orphan drug designation to Viamet's VT-1598

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...